Regardless of the sex-dependent roles of PPARγ, pioglitazone treatment suppressed the differentiation of Th17 cells in both male and female T cells, suggesting that PPARγ is an important target to modulate Th17-mediated autoimmune diseases. The gene discussed is PPARG; the disease is autoimmune disease.